Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-21Clinical Trial Update: SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma [Phase 2]
Pfizer-sponsored Phase 2 study of SU011248 for bevacizumab-refractory metastatic renal cell carcinoma has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: PS-341 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluating PS-341 (bortezomib) in metastatic renal cell carcinoma (kidney cancer) has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine with or without imatinib mesylate in metastatic or unresectable kidney cancer; the study status is term…
-
CLINICAL_TRIALS trial_result · 2009-12-10Clinical Trial Update: SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 trial comparing SU011248 to Interferon alfa as first-line therapy for metastatic renal cell carcinoma has completed and results have…
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. [Phase 2]
A pivotal Phase 2 trial of SU011248 in cytokine-refractory metastatic renal cell carcinoma has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-10-19FDA Approved: VOTRIENT — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved VOTRIENT (pazopanib hydrochloride) under an Original Application for cancer indications, marking pazopanib’s initial approval.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: A Phase II Study of AS1411 in Renal Cell Carcinoma [Phase 2]
A Phase II clinical trial of AS1411 for metastatic renal cell carcinoma is noted, with the study status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma [Phase 1]
This document reports the completion of a Phase 1 study evaluating AS1409 in patients with metastatic renal cell carcinoma or metastatic mal…
-
CLINICAL_TRIALS research · 2009-07-28Clinical Trial Update: Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma
Clinical trial update on a laparoendoscopic single-site radical nephrectomy for localized renal cell carcinoma; the current status of the tr…
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 study evaluating conditioning regimens for nonmyeloablative allogeneic hematopoietic stem cell transplantation in renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer [Phase 2]
A Phase 2 study evaluating continuous daily dosing of sunitinib (SU011248) in patients with advanced renal cell carcinoma; results have been…
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating recombinant interleukin-21 in combination with sorafenib for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens [Phase 2]
This Phase 2 clinical trial investigated the combination of capecitabine and interferon-Alpha in patients with metastatic renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib [Phase 1, Phase 2]
This update covers a Phase 1/2 clinical trial evaluating autologous vaccination for stage 4 renal cell carcinoma in combination with Sunitin…
-
CLINICAL_TRIALS trial_result · 2009-04-14Clinical Trial Update: A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of thalidomide and capecitabine in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R) [Phase 2]
A Phase 2 trial evaluating sunitinib with or without bevacizumab in first-line metastatic renal cell carcinoma was terminated; results were …
-
FDA approval · 2009-03-30FDA Approved: AFINITOR — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved the original application for Afinitor (everolimus) from Novartis, granting marketing authorization for its use in treating …
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) [Phase 2]
Phase 2 clinical trial update on PF-3512676 (CPG 7909) for patients who completed an oncology study using the drug. The document notes that …
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer [Phase 1]
Phase 1 study evaluating Interleukin-21 for metastatic malignant melanoma and metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial evaluating whether adding interleukin-2 to sorafenib improves outcomes as first-line therapy in advanced renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: CPG 7909 in Patients Wih Stage IV Renal Cell Cancer [Phase 1, Phase 2]
Pfizer-sponsored CPG 7909 was evaluated in a Phase 1/2 trial for stage IV renal cell carcinoma and the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 3]
A Phase 3 trial comparing interferon alfa-2b with or without thalidomide in patients with metastatic or unresectable kidney cancer has compl…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC [Phase 2]
Phase 2 clinical trial evaluating a mixture of G, C, and S for renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-11Clinical Trial Update: A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients [Phase 1]
A completed Phase I trial evaluating the combination of bevacizumab and sunitinib in patients with metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2008-09-15Clinical Trial Update: Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment [Phase 2]
Phase 2 study evaluating continuation of panitumumab in patients who previously benefited and tolerated the drug has completed.